SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Organovo Holdings, Inc. (ONVO)

Add ONVO Price Alert      Hide Sticky   Hide Intro
Moderator: dshade, Dadx4
Search This Board: 
Last Post: 3/24/2017 10:18:30 AM - Followers: 320 - Board type: Free - Posts Today: 3


     Organovo is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications.
The company's NovoGen three-dimensional bioprinting technology is a platform that works across all tissue and cell types.
Organovo's NovoGen MMX Bioprinter was selected as one of the "Best Inventions of 2010" by TIME Magazine.
Organovo is helping pharmaceutical partners develop human biological disease models in three dimensions that enable therapeutic drug discovery and development.
Organovo's bioprinting technology can also be developed to create surgical tissues direct therapy.
Organovo leads the way in solving complex medical research problems and building the future of medicine.


ONVO Security Details Share Structure

Shares Outstanding 77,816,787 a/o Mar 16, 2014
Float 50,000,000 a/0 May24,2014
Authorized Shares 150,000,000 a/o May24, 2014

IR and Media Contacts:
Investor Relations Contact: [email protected]
Media Contact: [email protected]

Mailing Address:
Organovo, Inc.
6275 Nancy Ridge Drive, Suite 110
San Diego, CA 92121
Phone: 1-858-550-9994

For all the latest company information, details, news, please visit

Organovo's Scientific Founder and Chief Scientific Officer, Dr. Gabor Forgacs
is the Executive and Scientific Director of the Shipley Center for Innovation at Clarkson University and the George H. Vineyard Professor of Biological Physics at the University of Missouri.
He developed Organovo's breakthrough organ printing technology while leading a team of top regenerative medicine scientists from multiple universities, with the backing of a $5MM National Science Foundation Grant.
Professor Forgacs is the author of more than 150 peer reviewed journal articles and the textbook Biological Physics of the Developing Embryo, (with Stuart Newman), published by Cambridge University Press.
He holds a PhD in theoretical physics from the Roland Eotvos University, Budapest Hungary. He moved to the United States in the 1980's from the Institute of Physics of the French Atomic Energy Agency in Saclay to accept a professorship at Clarkson University. 
University of Missouri researcher doing groundbreaking work in regenerative medicine. Here is a video:


Organovo strives to advance regenerative medicine to new heights, by enabling bioprinting tissues and 3-D cellular constructs that were not possible before.
The novel and flexible capabilities of the bioprinting technology allow researchers to generate data faster and more efficiently, thus leading to cutting edge scientific findings, publications, and grants.

Organovo's 3-D NovoGen bioprinting technology allows for the placement of cells in any pattern desired.
First, small building blocks of any shape are created from the desired cell type.
Second, these pre-formed cell aggregates are loaded into a print cartridge that is then attached to the bio-printer.
The bioprinter deposits the cell aggregates one layer at a time, creating multiple stacked 2-D patterns.
A non-invasive gel is placed next to the cell aggregates to hold the desired 3-D shape as each layer is placed in 2-D.

After printing, the cell aggregates retain enough cellular mobility for them to flow into one another, creating a fused tissue construct.
The principles of developmental biology, including cellular self-assembly, allow the final construct to mature into the desired shape and properties.


World class support for NovoGen MMX

The NovoGen MMX Bioprinter™ is supported by our scientific and engineering team.
Every customer receives bioprinter training and access to Organovo's scaffold-free proprietary bioprinting process, which includes cell preparation to tissue maturation.
Additional consultation and application support are available upon request. Organovo's success comes from enabling our customers' success.  


NovoGen MMX Bioprinter

    The NovoGen MMX Bioprinter™ is a novel hardware and software platform at the forefront of bioprinting research and development. The NovoGen MMX™ was developed to meet challenges in biological research.
The platform takes primary or other human cells and shapes them into 3D tissue, with tremendous cellular viability and biology that is superior to even an animal model.
The platform is being used by Organovo's Pharma partners today to enable cutting edge research into drug discovery.

By allowing creation of three dimensional biological structures, Organovo creates functional human tissue that is superior to current disease models.
By enabling printing of tissue in a laboratory environment, investigations on the constructs can be integrated into your current analysis methods. (at 28 sec into the video is a full frontal view of the ONVO NovaGen MMX Bioprinter)

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
ONVO News: Organovo and Its Customers Present Data Supporting 3D Bioprinted Liver and Kidney Tissues for Drug Toxicity Testing 03/13/2017 08:05:00 AM
ONVO News: Organovo to Present at 29th Annual Roth Conference 03/09/2017 08:05:00 AM
ONVO News: Statement of Changes in Beneficial Ownership (4) 02/21/2017 06:05:27 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 02/21/2017 06:04:05 PM
ONVO News: Statement of Changes in Beneficial Ownership (4) 02/21/2017 06:02:43 PM
#9723  Sticky Note Organovo Signs Exclusive Distributor Agreement With Cosmo Bio (Japan) Dadx4 12/14/16 08:25:51 AM
#6071  Sticky Note ONVO Kidney news & Profile videos dshade 05/24/14 12:15:04 PM
#9928   thanks, alvie. nasdaq is also showing it trading. morley480 03/24/17 10:18:30 AM
#9927   IH doesn't show any trading - Fidelity has Alvie 03/24/17 10:15:48 AM
#9926   is this trading today? many thanks. morley480 03/24/17 10:04:41 AM
#9925   I should say those that are using the thewind 03/20/17 07:52:16 PM
#9924   Aether (sp?) crowd, is an odd turn of WHP03 03/20/17 11:31:56 AM
#9923   The Aether crowd... thewind 03/18/17 08:37:07 AM
#9922   Yeah nice day. Go green. :-) rayank 03/17/17 04:16:51 PM
#9921   While I will never pump a stock I Dadx4 03/17/17 03:49:51 PM
#9920   Weeeeeeeeeeee jjh573 03/17/17 03:45:38 PM
#9919   Blah blah blah... blah blah blah... whatever you WHP03 03/16/17 12:21:50 AM
#9918   Blah blah blah Miji - blah blah blah WHP03 03/16/17 12:20:42 AM
#9917   $ONVO Mr, Murphy's testimony runs from 24:30 to WHP03 03/16/17 12:19:58 AM
#9916   The excitement is through the roof... lol ONVO$$$$$$$ jjh573 03/15/17 06:41:10 PM
#9915   Agreed. ONVO--GLTA! Dadx4 03/15/17 06:32:53 PM
#9914   Good day here! ONVO$$$$$$$ jjh573 03/15/17 05:03:21 PM
#9913   Nice psar flip on the daily, looking for jjh573 03/15/17 01:48:02 PM
#9912   Picked up some @$2.91 this looks ready to jjh573 03/14/17 11:04:26 AM
#9911   Organovo and Its Customers Present Data Supporting 3D rayank 03/13/17 08:14:06 AM
#9910   Would like to know more about the patents thewind 03/11/17 10:19:06 AM
#9909   Zacks has always been a joke on such WHP03 03/10/17 07:31:02 PM
#9908   It's a program based on price that publishes thewind 03/10/17 05:33:04 PM
#9907   That is strange. Maybe try to contact Zacks? rayank 03/10/17 05:19:36 PM
#9906   Someone can't make up their flippen mind.... really, RandolRocketman 03/10/17 04:54:14 PM
#9905   blah blah blah, negative just to be negative... WHP03 03/09/17 11:49:17 PM
#9904   So Mr. Kussman is going out for a miji 03/09/17 08:57:16 PM
#9903   I can see your cheek sticking out thewind 03/08/17 09:49:41 AM
#9902   That's right this is a scam stinky pinky RandolRocketman 03/08/17 08:23:20 AM
#9901   Can't argue with the logic of your suspicions... WHP03 03/07/17 10:57:07 PM
#9900   Is a bit arbitrary with that one. thewind 03/07/17 07:28:21 PM
#9899   What seems suspect to me is that you Alvie 03/07/17 06:22:05 PM
#9898   there is no proof bioprinters work for toxicity miji 03/07/17 05:34:19 PM
#9897   Well I don't know about all that, I'm RandolRocketman 03/04/17 09:17:03 PM
#9896   Interesting word picture.... I am afraid it's more WHP03 03/03/17 11:37:30 AM
#9895   Unless something major happens specifically to Organovo thewind 03/02/17 08:43:03 PM
#9892   It's a volunteer thing, for those interested. morley480 02/24/17 02:03:31 PM
#9890   Go to this page TedJ 02/23/17 07:41:54 PM
#9888   What does a good moderator do... and how WHP03 02/23/17 04:40:06 PM
#9885   Samsara is simply part of ONVO's supply chain WHP03 02/23/17 09:40:04 AM
#9884   Yes! Only differences is value exist. Unfortunately, it's thewind 02/23/17 07:24:39 AM
#9883   Interesting reference: WHP03 02/23/17 12:44:24 AM
#9882 Ballgame 02/23/17 12:06:56 AM
#9881   Agreed The possibility of a patch is what needs thewind 02/22/17 09:07:30 PM
#9880   Sales increases are the only answer unless they riaguy 02/22/17 05:35:13 PM
#9879   It's always about revenue growth, which is why WHP03 02/22/17 01:17:00 PM
#9878   The interest will be subdued thewind 02/22/17 12:33:34 PM
#9877   Not sure about the latter being accurate, but WHP03 02/21/17 09:04:38 PM
#9875   so they tooted their horn? thewind 02/21/17 10:33:35 AM
#9874   Organovo Publishes Data Describing Physiology of 3D Bioprinted Dadx4 02/21/17 08:56:56 AM
#9873   ONVO's founder is already doing that (to produce WHP03 02/19/17 07:46:54 PM
#9872   I say they team up with the Iowa tyfoidhana 02/18/17 11:54:26 PM